#OpenAI

OpenAI, one of the world’s leading artificial intelligence developers, has sounded an alarm over the impending arrival of AI systems with powerful capabilities in the field of biology—warning that the next wave of models may reach a “high-risk classification” due to their potential for misuse, including the development of biological threats and weapons. This development marks a pivotal moment as AI becomes increasingly capable not just of assisting scientific research but also of introducing new biosecurity risks and ethical challenges that affect societies worldwide, including Thailand. (OpenAI, SiliconANGLE)

The global debate over the risks posed by artificial intelligence (AI) has reached a new fever pitch, with leading researchers, tech executives, and policymakers openly questioning whether AI could one day pose a true existential threat to humanity. Recent studies and expert panels have challenged both alarmist and skeptical views—and reveal that public concern may be more nuanced than headlines suggest.

Recent months have seen questions about AI’s potential for disaster take centre stage in academic journals, global news media, and even in major tech conferences. The high-profile article “Behind the Curtain: What if predictions of humanity-destroying AI are right?” published by Axios, thrusts this conversation into urgent focus. The central question: What if the so-called “AI doomers” are correct, and humanity is genuinely at risk from the unchecked development of intelligent machines capable of self-improvement or unpredictable behaviour? This provocative scenario is not limited to science fiction; it now commands the attention of some of the world’s leading scientific minds and regulatory bodies.

A groundbreaking study by Harvard University has found that GPT-4o, OpenAI’s latest large language model, exhibits behaviors akin to human cognitive dissonance—a psychological phenomenon previously thought to be exclusively human. The findings, reported in the prestigious Proceedings of the National Academy of Sciences on May 28, 2025, raise fresh questions about how advanced AI systems process information and make decisions, carrying significant implications for Thailand’s growing embrace of AI-driven technology in education, health, and society at large (TechXplore).

The US Food and Drug Administration (FDA) is engaging in active discussions with technology company OpenAI as part of a broader push to modernize drug evaluation with artificial intelligence. According to recent reporting by Wired, such collaboration could mark a pivotal shift in how new medicines are reviewed—potentially reducing the time it takes to bring life-saving drugs to market, and setting global trends that are closely watched in Thailand and across Asia Wired.

A new wave of powerful artificial intelligence systems—from leading global tech companies like OpenAI, Google, and DeepSeek—are increasingly generating factual errors despite their advanced capabilities, sparking growing concerns among users, researchers, and businesses worldwide. As these A.I. bots become more capable at tasks like complex reasoning and mathematics, their tendency to produce incorrect or entirely fabricated information—known as “hallucinations”—is not only persisting but actually worsening, as revealed in a recent investigative report by The New York Times (nytimes.com).

Artificial Intelligence systems, particularly the large language models that drive today’s chatbots and virtual assistants, are experiencing a troubling twist in their evolution: the more advanced and “intelligent” they become, the more likely they are to fabricate convincing but false information—a phenomenon known as AI hallucination. New research and industry reporting reveal that the latest generation of “reasoning” AI models, despite appearing more capable and articulate, are showing a dramatic increase in these errors, raising serious concerns for everyday users and global industries alike.